申请人:PORTOLA PHARM INC
公开号:WO2005035520A1
公开(公告)日:2005-04-21
Isoquinolinone compounds are provided that are useful for the inhibition of ADP-platelet aggregation, particularly in the treatment of thrombosis and thrombosis related conditions or disorders.
提供了对异喹啉酮化合物,这些化合物对于抑制ADP-血小板聚集特别有用,尤其在治疗血栓形成和与血栓形成相关的疾病或疾病时。